Conformational preferences of the pyrrolidine ring in nucleotide analogs 7-14 were investigated by means of NMR and molecular modeling. The effect of the relative configuration of hydroxy and nucleobase substituents as well as the effect of the alkylation or acylation of the pyrrolidine nitrogen atom on the conformation of the pyrrolidine ring were studied. The results of a conformational analysis show that the alkylation/acylation can be effectively used for tuning the pyrrolidine conformation over the whole pseudorotation cycle.

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic Flemingovo nám 2 166 10 Prague 6 Czech Republic

See more in PubMed

De Clercq E, Sakuma T, Baba M, Pauwels R, Balzarini J, Rosenberg I, Holý A. Antiviral Res. 1987;8:261–272. doi: 10.1016/S0166-3542(87)80004-9. PubMed DOI

Balzarini J, Naesens L, Herdewijn P, Rosenberg I, Holý A, Pauwels R, Baba M, Johns D G, De Clercq E. Proc Natl Acad Sci U S A. 1989;86:332–336. doi: 10.1073/pnas.86.1.332. PubMed DOI PMC

Mackman R L, Boojamra C G, Prasad V, Zhang L, Lin K-Y, Petrakovsky O, Babusis D, Chen J, Douglas J, Grant D, et al. Bioorg Med Chem Lett. 2007;17:6785–6789. doi: 10.1016/j.bmcl.2007.10.038. PubMed DOI

Kočalka P, Rejman D, Vaněk V, Rinnová M, Tomečková I, Králiková Š, Petrová M, Páv O, Pohl R, Buděšínský M, et al. Bioorg Med Chem Lett. 2010;20:862–865. doi: 10.1016/j.bmcl.2009.12.081. PubMed DOI

Rejman D, Panová N, Klener P, Maswabi B, Pohl R, Rosenberg I. J Med Chem. 2012;55:1612–1621. doi: 10.1021/jm201409u. PubMed DOI

Keough D T, Hocková D, Rejman D, Špaček P, Vrbková S, Krečmerová M, Eng W S, Jans H, West N P, Naesens L M J, et al. J Med Chem. 2013;56:6967–6984. doi: 10.1021/jm400779n. PubMed DOI

Freier S M, Altmann K-H. Nucleic Acids Res. 1997;25:4429–4443. doi: 10.1093/nar/25.22.4429. PubMed DOI PMC

Karplus M. J Am Chem Soc. 1963;85:2870–2871. doi: 10.1021/ja00901a059. DOI

Altona C, Sundaralingam M. J Am Chem Soc. 1972;94:8205–8212. doi: 10.1021/ja00778a043. PubMed DOI

De Leeuw F A A M, Altona C. J Comput Chem. 1983;4:428–437. doi: 10.1002/jcc.540040319. DOI

Padrta P, Sklenář V. J Biomol NMR. 2002;24:339–349. doi: 10.1023/A:1021656808607. PubMed DOI

Hendrickx P M S, Martins J C. Chem Cent J. 2008;2:No. 20. doi: 10.1186/1752-153X-2-20. PubMed DOI PMC

Sharma N K, Ganesh K N. Tetrahedron. 2010;66:9165–9170. doi: 10.1016/j.tet.2010.09.082. DOI

Watts J K, Sadalapure K, Choubdar N, Pinto B M, Damha M J. J Org Chem. 2006;71:921–925. doi: 10.1021/jo051844+. PubMed DOI

Rejman D, Kočalka P, Buděšínský M, Pohl R, Rosenberg I. Tetrahedron. 2007;63:1243–1253. doi: 10.1016/j.tet.2006.11.047. DOI

Christensen J J, Rytting J H, Izatt R M. J Phys Chem. 1967;71:2700–2705. doi: 10.1021/j100867a047. PubMed DOI

Christensen J J, Rytting J H, Izatt R M. Biochemistry. 1970;9:4907–4913. doi: 10.1021/bi00827a012. PubMed DOI

De Leeuw H P M, Haasnoot C A G, Altona C. Isr J Chem. 1980;20:108–126. doi: 10.1002/ijch.198000059. DOI

Houseknecht J, Altona C, Hadad C M, Lowary T L. J Org Chem. 2002;67:4647–4651. doi: 10.1021/jo025635q. PubMed DOI

Rejman D, Pohl R, Kočalka P, Masojídková M, Rosenberg I. Tetrahedron. 2009;65:3673–3681. doi: 10.1016/j.tet.2009.02.071. DOI

Becke A D. J Chem Phys. 1993;98:5648–5652. doi: 10.1063/1.464913. DOI

Lee C, Yang W, Parr R G. Phys Rev B. 1988;37:785–789. doi: 10.1103/PhysRevB.37.785. PubMed DOI

Cossi M, Rega N, Scalmani G, Barone V. J Comput Chem. 2003;24:669–681. doi: 10.1002/jcc.10189. PubMed DOI

Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor